TweenVax: A Comprehensive Practice-, Provider-, and Parent/Patient-Level Intervention to Improve Adolescent HPV Vaccination

Summary

This clinical trial compares the effect of a vaccine promotional intervention, TweenVax, to standard of care vaccination promotion practices on rates of human papillomavirus (HPV) vaccination in adolescents. HPV vaccination has been identified as a priority for cancer prevention and control by the Cancer Moonshot Blue Ribbon Panel, which estimated that increasing HPV vaccination rates can prevent 400,000 HPV-related cancers in the next 5-10 years. The goal is for HPV vaccinations to be completed by the age of 13. It has been estimated that only about 16% of adolescents were fully up to date with HPV vaccines by age 13. Strong and consistent provider recommendations have been shown to play an important role in the uptake of vaccines. In addition, education and information received by parents may improve the strength of recommendations by providers. The TweenVax intervention includes practice, provider, parent and patient level education to teach best practices, help with vaccine messaging, and give correct and easy to understand information to parents. Providing practice, provider and parent level access to TweenVax may be more effective than current vaccine promotion practices in improving HPV vaccination rates in adolescents.

Description

Eligibility

Age range

9+ years

Sex

All

Healthy volunteers

Yes

Interventions

• Other
  Best Practice

  Offer standard of care adolescent vaccination promotion practices

• Other
  Educational Intervention

  Receive vaccination information

• Other
  Health Promotion and Education

  Receive all TweenVax components and trainings for the practice, providers and staff, parents and adolescents

• Other
  Health Promotion and Education

  Receive components and trainings for the practice and provider levels

• Other
  Internet-Based Intervention

  Receive access to TweenVax application

Location